Your browser doesn't support javascript.
loading
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential.
Wang, Liqin; Leite de Oliveira, Rodrigo; Huijberts, Sanne; Bosdriesz, Evert; Pencheva, Nora; Brunen, Diede; Bosma, Astrid; Song, Ji-Ying; Zevenhoven, John; Los-de Vries, G Tjitske; Horlings, Hugo; Nuijen, Bastiaan; Beijnen, Jos H; Schellens, Jan H M; Bernards, Rene.
Afiliação
  • Wang L; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Leite de Oliveira R; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Huijberts S; Division of Clinical Pharmacology, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Bosdriesz E; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Pencheva N; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Brunen D; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Bosma A; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Song JY; Division of Molecular Genetics, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Zevenhoven J; Division of Molecular Genetics, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Los-de Vries GT; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Horlings H; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Nuijen B; Department of Pharmacy and Pharmacology, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Beijnen JH; Department of Pharmacy and Pharmacology, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Schellens JHM; Division of Clinical Pharmacology, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Bernards R; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands. Electronic address: r.bernards@nki.nl.
Cell ; 173(6): 1413-1425.e14, 2018 05 31.
Article em En | MEDLINE | ID: mdl-29754815
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Resistencia a Medicamentos Antineoplásicos / Melanoma Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Resistencia a Medicamentos Antineoplásicos / Melanoma Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article